COPD: From obstructive lung disease to chronic systemic inflammatory syndrome?;COPD: Von einer obstruktiven Lungenerkrankung zu einem chronischen, systemischen Entzündungssyndrom?

Pneumologie

Volumn 63, Issue SUPPL. 2, 2009, Pages

  Wouters, E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; HEART DISEASE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LUNG FUNCTION; METABOLIC SYNDROME X; NEOPLASM; OBESITY; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYNDROME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77949341704     PISSN: 09348387     EISSN: 14388790     Source Type: Journal    
DOI: 10.1055/s-0029-1214728     Document Type: Review

References (18)

1. Rabe K F., Hurd S, Anzueto A et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. GOLD Executive Summary. Am J Respir Crit Care Med 2007 176 532-555
2. Coxson H. Personal communication.
3. Makita H, Nasuhara Y, Betsuyaku T et al. Characterization of phenotypes based on severity of emphysema in chronic pulmonary disease. Thorax 2007 62 932-937
4. Patel B D., Coxson H O., Pillai S G. et al. Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 2008 178 500-505
5. Hogg J C., Chu F, Utokaparch S et al. The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease. NEJM 2004 350 2645-2653
6. Teo K K., Ounpuu S, Hawken S et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006 368 647-658
7. Anthonisen N R., Connett J E., Enright P L. et al. Hospitalizations and Mortality in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine 2002 166 333-339
8. Johnston A K., Mannino D M., Hagan G W. et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008 63 599-605
9. Curkendall S M., DeLuise C, Jones J K. et al. Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada: Cardiovascular Disease in COPD Patients. Ann Epidemiol 2006 16 63-70
10. Sevenoaks M J., Stockley R A. Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory phenotype? Respir Res 2006 7 70
11. Gosker H R., Engelen M, van Mameren H et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. American Journal of Clinical Nutrition 2002 76 113-119
12. Doucet M, Russell A P., Lger B et al. Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 2007 176 261-269
13. Breyer M K., Spruit M, Rutten E et al. Metabolic syndrome(MS) in COPD patients entering pulmonary rehabilitation(PR). ERS congress Berlin 2008 Abstract 1326, p. 222s
14. McClean K M., Kee F, Young I S. et al. Obesity and the lung: Epidemiology. Thorax 2008 63 649-654
15. Adams K F., Schatzkin A, Harris T B. et al. Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old. NEJM 2006 355 763-778
16. Kahn R. Metabolic syndrome what is the clinical usefulness? Lancet 2008 371 1892-1893
17. De Martinis M, Franceschi C, Monti D et al. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006 80 219-227
18. Dali-Youcef N, Lagouge M, Froelich S et al. Sirtuins: the magnificent seven, function, metabolism and longevity. Ann Med 2007 39 335-345